REN and Hypertension: The median age of the breast cancer group was 53 years (range, 32–74 years), they had a mean body mass index of 30 kg/m2 and minimal cardiovascular comorbidities with only 2 (8%) participants receiving renin-angiotensin inhibitor treatment for hypertension.